{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:57:25Z","timestamp":1793228245009,"version":"4.5.0"},"reference-count":276,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The interplay between the immune system and leukemia presents major challenges to effective therapy development. This Review examines mechanisms of immune evasion across leukemia subtypes, emphasizing T-cell exhaustion, regulatory T cells (Tregs), and antigen-presentation deficits. Globally, leukemia remains a significant burden, with approximately 460,000 new cases and 320,000 deaths estimated in 2021 alone. Recent studies reveal how the tumor microenvironment (TME) shapes immune behavior and how leukemic cells remodel it to support survival and therapeutic resistance. We illustrate these adaptive processes, highlighting the contributions of the bone-marrow niche and B-cell dysregulation in chronic lymphocytic leukemia (CLL). We further discuss implications for immunotherapy, noting that agents like magrolimab (anti-CD47) combined with azacitidine have demonstrated objective response rates (ORR) exceeding 80% in early-phase AML trials, though challenges such as on-target anemia persist. By integrating current evidence from preclinical metabolic profiling to Phase 3 clinical data on E-selectin inhibition (uproleselan)\u2014we clarify the immune landscape of leukemia and outline avenues for innovative treatments. Ultimately, this Review underscores the need for multifaceted immunotherapeutic approaches that account for the complex interactions within the TME.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1743920","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:36:54Z","timestamp":1770359814000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The tumor microenvironment in leukemia: molecular pathways of immune evasion"],"prefix":"10.3389","volume":"17","author":[{"given":"Ying","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion, First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Liu","sequence":"additional","affiliation":[{"name":"Basic Medical College of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"You","sequence":"additional","affiliation":[{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirui","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqiang","family":"Zeng","sequence":"additional","affiliation":[{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Song","sequence":"additional","affiliation":[{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanrong","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Lu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshuo","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Hematology, First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Medical Technology, Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1315453","article-title":"Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia","volume":"14","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/14737140.2025.2483855","article-title":"Contemporary understanding of myeloid-derived suppressor cells in the acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) tumor microenvironment","volume":"25","author":"Alhajahjeh","year":"2025","journal-title":"Expert Rev Anticancer Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082307","article-title":"Extracellular vesicles in chronic lymphocytic leukemia: tumor microenvironment messengers as a basis for new targeted therapies","volume":"15","author":"Dubois","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/life15060937","article-title":"Galectin-3 release in the bone marrow microenvironment promotes drug resistance and relapse in acute myeloid leukemia","volume":"15","author":"Y\u0131ld\u0131r\u0131m","year":"2025","journal-title":"Life"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.606540","article-title":"Toward therapeutic targeting of bone marrow leukemic niche protective signals in B-cell acute lymphoblastic leukemia","volume":"10","author":"Delahaye","year":"2021","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/biomedicines12102306","article-title":"Macrophages as potential therapeutic targets in acute myeloid leukemia","volume":"12","author":"Mesaros","year":"2024","journal-title":"Biomedicines"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/children8050371","article-title":"Far from health: the bone marrow microenvironment in AML, A leukemia supportive shelter","volume":"8","author":"Sendker","year":"2021","journal-title":"Children"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3390\/curroncol30070455","article-title":"Tumor-associated macrophages in multiple myeloma: key role in disease biology and potential therapeutic implications","volume":"30","author":"Cencini","year":"2023","journal-title":"Curr Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1182\/blood-2024\u2013211180","article-title":"Multidimensional analysis of relapsed bone marrow reveals cold immune microenvironment post-TMLI in acute leukemia transplant patients","volume":"144","author":"Madabushi","year":"2024","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.18502\/jzms.v5i4.11796","article-title":"Exosomes and their impact on chronic myeloid leukemia; from its progression to the treatment","volume":"5","author":"Roshandel","year":"2023","journal-title":"J Zabol Med School"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00277-025-06237-w","article-title":"Tumor microenvironment as a novel therapeutic target for lymphoid leukemias","volume":"104","author":"Mousavi","year":"2025","journal-title":"Ann Hematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ejh.14224","article-title":"Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review","volume":"113","author":"Taghiloo","year":"2024","journal-title":"Eur J Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010250","article-title":"Fatty acid metabolism in myeloid-derived suppressor cells and tumor-associated macrophages: key factor in cancer immune evasion","volume":"14","author":"Siddiqui","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1186\/s12967-024-05963-5","article-title":"Unraveling the interplay of CD8 + T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches","volume":"22","author":"Touchaei","year":"2024","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10238-025-01795-9","article-title":"The AML immune paradox: decoding escape pathways and pioneering checkpoint, vaccine, and combination strategies","volume":"25","author":"Samarkhazan","year":"2025","journal-title":"Clin Exp Med (Testo stampato)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060826","article-title":"Role of tumor microenvironment in prostate cancer immunometabolism","volume":"15","author":"Wang","year":"2025","journal-title":"Biomolecules"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612244","article-title":"T cells in chronic lymphocytic leukemia: A two-edged sword","volume":"11","author":"Vlachonikola","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10238-025-01764-2","article-title":"Targeting acute myeloid leukemia through antibody engineering: innovations in immunotherapy and combination regimens","volume":"25","author":"Samarkhazan","year":"2025","journal-title":"Clin Exp Med (Testo stampato)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1097\/MS9.0000000000003295","article-title":"The role of cytokines in pediatric hematologic Malignancies: mechanisms of tumor progression and therapeutic implications \u2013 a narrative review","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann Med Surgery"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2023.12.004","article-title":"Role of the tumor microenvironment in CLL pathogenesis","volume":"61","author":"Stein","year":"2023","journal-title":"Semin Hematol (Print)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235912","article-title":"Targeting metabolism to control immune responses in cancer and improve checkpoint blockade immunotherapy","volume":"13","author":"Luby","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40364-024-00643-4","article-title":"Single-cell sequencing to multi-omics: technologies and applications","volume":"12","author":"Wu","year":"2024","journal-title":"biomark Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-024-01596-9","article-title":"Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications","volume":"17","author":"Liu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312940","article-title":"Innovative insights into single-cell technologies and multi-omics integration in livestock and poultry","volume":"25","author":"Lu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1360\/TB-2024-1403","article-title":"Advances in spatial multi-omics technologies","volume":"71","author":"Zhang","year":"2025","journal-title":"Chin Sci Bulletin"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40364-024-00654-1","article-title":"Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era","volume":"12","author":"Xiong","year":"2024","journal-title":"biomark Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","article-title":"Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment","volume":"24","author":"Le","year":"2025","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1636483","article-title":"Single-cell technologies and spatial transcriptomics: decoding immune low - response states in endometrial cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ph18010075","article-title":"Leveraging single-cell multi-omics to decode tumor microenvironment diversity and therapeutic resistance","volume":"18","author":"Sabit","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","article-title":"Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy","volume":"43","author":"Guo","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1186\/s12885-023-11630-7","article-title":"MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1182\/blood-2024-203863","article-title":"Single-cell transcriptomic and spatial characterization of multipotent stromal cells in homeostatic,Remodeled, and in vitro expanded human bone marrow","volume":"144","author":"Bataclan","year":"2024","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ccs3.70009","article-title":"Favorable and poor prognosis B-cell precursor acute lymphoblastic leukemia subtypes reveal distinct leukemic cell properties when interacting with mesenchymal stem cells, differentially modifying their cell stemness and leukemia chemoresistance","volume":"19","author":"Santiago","year":"2025","journal-title":"J Cell Commun Signal"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202508940","article-title":"Leukemic cells hijack stromal bioelectricity to reprogram the bone marrow niche via caV1.2-dependent mechanisms","volume":"12","author":"Da Ros","year":"2025","journal-title":"Adv Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.10.642319","article-title":"Leukemic cells manipulate MSCs bioelectrical signals to reshape the bone marrow niche","author":"Borella","year":"2025","journal-title":"bioRxiv"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.1038\/s41598-024-58860-8","article-title":"Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia","volume":"14","author":"Palani","year":"2024","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.3390\/cancers15153931","article-title":"Cordycepin (3dA) induces cell death of AC133+ Leukemia cells via re-expression of WIF1 and down-modulation of MYC","volume":"15","author":"Abazari","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1182\/blood-2019-128592","article-title":"Daratumumab inhibits AML metabolic capacity and tumor growth through inhibition of CD38 mediated mitochondrial transfer from bone marrow stromal cells to blasts in the leukemic microenvironment","volume":"134","author":"Mistry","year":"2019","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3249.AML23-A27","article-title":"Abstract A27: Cellular barcoding of the leukemic niche reveals an apelin-mediated clonal expansion of niche endothelial and mesenchymal stromal cell clones","volume":"4","author":"Baron","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1101\/2024.09.09.612077","article-title":"Leukemia-derived apelin selects endothelial niche clones to promote tumorigenesis","author":"Baron","year":"2024","journal-title":"bioRxiv"},{"key":"B41","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2024-205448","article-title":"High throughput and long-term human bone marrow perivascular organoids to study tumor microenvironment and drug sensitivity in acute myeloid leukemia","volume":"144","author":"Janon","year":"2024","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba5536","article-title":"Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche","volume":"6","author":"Ma","year":"2020","journal-title":"Sci Adv"},{"key":"B43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1182\/blood-2024-203714","article-title":"Single-cell spatial transcriptomics identifies lymphoid aggregates with location-specific alterations of adaptive immune cells in human MDS bone marrow","volume":"144","author":"Stanley","year":"2024","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiad039","article-title":"In vitro simulation of the acute lymphoblastic leukemia niche: a critical view on the optimal approximation for drug testing","volume":"114","author":"Pottosin","year":"2023","journal-title":"J Leukoc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.1182\/blood-2024-208465","article-title":"Leukemia associated macrophages and neutrophils contribute to immune suppression through PD-L1 and arginase in BCR-ABL1 chronic myeloid leukemia","volume":"144","author":"Liu","year":"2024","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1627161","article-title":"Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2016000984","article-title":"Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment","volume":"1","author":"Serra","year":"2016","journal-title":"Blood Adv"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-SITC2022.1154","article-title":"1154 High-potency synthetic STING agonists rewire myeloid subsets in the tumour microenvironment to dismantle immunosuppressive stroma in refractory pancreatic ductal adenocarcinoma","volume":"10","author":"Boda","year":"2022","journal-title":"Regular Young Investigator Award Abstracts"},{"key":"B49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1182\/blood-2024-194037","article-title":"Cross-talk between leukemic blasts and T cells drives targetable T cell dysfunction in the AML tumor microenvironment","volume":"144","author":"DeWolf","year":"2024","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1340634","article-title":"Extracellular matrix remodeling in the tumor immunity","volume":"14","author":"Du","year":"2024","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511527","article-title":"Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-\u03baB mediates chemoresistance","volume":"123","author":"Jacamo","year":"2014","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.3109\/10428199709055581","article-title":"VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells","volume":"24","author":"Oostendorp","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-5145","article-title":"Abstract 5145: E-selectin binding is enriched within B-cell acute lymphoblastic leukemia compared to healthy lymphoid precursors","volume":"85","author":"Weizer","year":"2025","journal-title":"Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030796","article-title":"Gap junctions in the bone marrow lympho-hematopoietic stem cell niche, leukemia progression, and chemoresistance","volume":"21","author":"Singh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1182\/blood-2020-142255","article-title":"The scaffolding protein NEDD9 regulates chronic lymphocytic leukemia cell migration via the CXCR4 - CXCL12 axis and promotes disease progression","volume":"136","author":"Rusyn","year":"2020","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41375-023-01897-x","article-title":"FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4\/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML","volume":"37","author":"Jia","year":"2023","journal-title":"Leukemia"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020335","article-title":"Targeting E-selectin to tackle cancer using uproleselan","volume":"13","author":"Muz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1182\/blood.V122.21.2889.2889","article-title":"Maintenance of bone marrow residency and self-renewal of leukemic stem cells by cdc42 gtpase","volume":"122","author":"Mizukawa","year":"2013","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1182\/blood-2024-204191","article-title":"Transforming growth factor beta 1\/SMAD2 signalling axis regulates leukemia stem cell marker CD123: implications for acute myeloid leukemia","volume":"144","author":"Taramsary","year":"2024","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adw4871","article-title":"Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML","volume":"11","author":"Gui","year":"2025","journal-title":"Sci Adv"},{"key":"B62","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13045-021-01133-y","article-title":"Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21037\/atm-23-1824","article-title":"Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression","volume":"12","author":"Urs","year":"2024","journal-title":"Ann Transl Med"},{"key":"B64","first-page":"51","article-title":"Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia","volume":"39","author":"Goda","year":"2023","journal-title":"bioRxiv"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3249.BCDSYMP24-P07","article-title":"Abstract P07: Identification of the unique preleukemic bone marrow niche in acute myeloid leukemia","volume":"5","author":"Goda","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094426","article-title":"The bone marrow niche in B-cell acute lymphoblastic leukemia: the role of microenvironment from pre-leukemia to overt leukemia","volume":"22","author":"Dander","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071536","article-title":"Mechanisms of immune evasion in acute lymphoblastic leukemia","volume":"13","author":"Pastorczak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215319","article-title":"Emerging bone marrow microenvironment-driven mechanisms of drug resistance in acute myeloid leukemia: tangle or chance","volume":"13","author":"Ciciarello","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28174","article-title":"Shedding of endogenous MHC class Irelated chain molecules A and B from different human tumor entities: Heterogeneous involvement of the \u201ca disintegrin and metalloproteases\u2019\u2019 10 and 17","volume":"133","author":"Chitadze","year":"2013","journal-title":"Int J Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.26083\/tuprints-00005914","article-title":"Investigation of a NKG2D-dependent tumor immune escape mechanism of head and neck squamous cell carcinoma and proof of concept of a clinical intervention strategy","author":"Weil","year":"2017","journal-title":"Dissertation in Technische Universit\u00e4t Darmstadt"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70192","article-title":"Enhancing macrophage phagocytosis of cancers by disrupting the SIRP\u03b1\/CD47 signaling axis and targeting MUC1 antigen","volume":"292","author":"Muneekaew","year":"2025","journal-title":"FEBS J"},{"key":"B72","first-page":"2111","article-title":"TLR3 agonism augments CD47 inhibition in acute myeloid leukemia","volume":"109","author":"Ramsey","year":"2023","journal-title":"Haematologica"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-553","article-title":"Abstract 553: Combined use of human iPSC-derived natural killer cells with macrophages and anti-CD47 blockade to improve killing of acute myeloid leukemia","volume":"82","author":"Goldenson","year":"2022","journal-title":"Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-149071","article-title":"Ppar\u03b1 Ablation suppresses T cell responses and anti-Tumor immunity by compromising the antigen-Presenting properties of tumor-Associated macrophages","volume":"138","author":"Christofides","year":"2021","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1182\/blood-2024-211349","article-title":"Leptin-enhanced JAK-STAT signaling in acute myeloid leukemia-derived mesenchymal stromal cells and its implications for disease progression","volume":"144","author":"Bhatti","year":"2024","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179841","article-title":"Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody","volume":"12","author":"Winkler","year":"2017","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1182\/blood.V118.21.3722.3722","article-title":"Prenyl transferases are involved in the regulation of CD20 levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity","volume":"118","author":"Nowis","year":"2011","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00262-010-0909-y","article-title":"In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors","volume":"59","author":"Berthon","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-34025-4_14","article-title":"The bone marrow niche - the tumor microenvironment that ensures leukemia progression","volume":"1219","author":"Cardoso","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B80","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","article-title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","volume":"32","author":"Kumar","year":"2017","journal-title":"Leukemia"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/25785826.2019.1698261","article-title":"Memory T cell, exhaustion, and tumor immunity","volume":"43","author":"Ando","year":"2019","journal-title":"Immunol Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-4838","article-title":"Abstract 4838: Epigenetic modulation of polyamine biosynthetic pathways rectifies T cell dysfunction to enhance anti-tumor immunity in lung cancer","volume":"85","author":"Tsai","year":"2025","journal-title":"Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.870283","article-title":"Inhibitory immune checkpoint receptors and ligands as prognostic biomarkers in COVID-19 patients","volume":"13","author":"Al-Mterin","year":"2022","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102718","article-title":"Beyond CTLA-4 and PD-1 inhibition: novel immune checkpoint molecules for melanoma treatment","volume":"15","author":"Ziogas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B85","first-page":"1","article-title":"Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells","volume":"16","author":"Greenberg","year":"2023","journal-title":"medRxiv"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14080802","article-title":"Mycobacterium tuberculosis modulates the expansion of terminally exhausted CD4+ and CD8+ T-cells in individuals with HIV-TB co-infection","volume":"14","author":"Sharma","year":"2025","journal-title":"Pathogens"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201504","article-title":"The PTPN2\/PTPN1 inhibitor abbv-CLS-484 augments immune responses against leukemic blasts and impedes leukemia cell proliferation in AML alone and in combination with venetoclax","volume":"622","author":"Kruppa","year":"2024","journal-title":"Blood"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1182\/blood-2019-125153","article-title":"Effect of avelumab to immune response in AML: A phase I study of avelumab in combination with decitabine as first line treatment of unfit patients","volume":"134","author":"Zheng","year":"2019","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","first-page":"xi4","DOI":"10.1093\/annonc\/mdz447.013","article-title":"Immune escape in acute myeloid leukemia","volume":"30","author":"Kuzelova","year":"2019","journal-title":"Ann Oncol"},{"key":"B90","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1182\/blood-2020-139134","article-title":"Single-cell roadmap of immune cell response in chronic myeloid leukemia","volume":"136","author":"Huuhtanen","year":"2020","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1080\/10428194.2022.2092853","article-title":"Phase 1b, open-label study evaluating the safety and pharmacokinetics of atezolizumab (anti\u2013PD-L1 antibody) administered in combination with Hu5F9-G4 to patients with relapsed and\/or refractory acute myeloid leukemia","volume":"63","author":"Daver","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"B92","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood.V114.22.3285.3285","article-title":"Differential effects of imatinib and dasatinib on immune effector cells in patients with chronic myeloid leukemia (CML)","volume":"114","author":"Rohon","year":"2009","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B95","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","article-title":"Induction and transcriptional regulation of the co-inhibitory gene module in T cells","volume":"558","author":"Chihara","year":"2018","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41590-021-00979-1","article-title":"Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans","volume":"22","author":"Yates","year":"2021","journal-title":"Nat Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4103\/aam.aam_5_24","article-title":"Correlation of T regulatory cells, cytotoxic T-lymphocyte-associated antigen 4, and transforming growth factor-\u03b21 with treatment response in patients with chronic myeloid leukemia receiving dasatinib therapy","volume":"24","author":"Singh","year":"2024","journal-title":"Ann Afr Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1486868","article-title":"CD73: a new immune checkpoint for leukemia treatment","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.31.630890","article-title":"Trogocytosis-mediated transfer of FOLR2 from Nurse-like cells to CLL cells is linked to their activation and proliferation","author":"Domagala","year":"2025","journal-title":"bioRxiv"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.108","article-title":"Nurse-like cells impact on disease progression in chronic lymphocytic leukemia","volume":"6","author":"Boissard","year":"2016","journal-title":"Blood Cancer J"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood.V130.Suppl_1.3007.3007","article-title":"Nurse-like cells express high-levels of wnt5a, which induces ROR1-dependent signaling that promotes migration and survival of neoplastic cells in chronic lymphocytic leukemia","volume":"130","author":"Chen","year":"2017","journal-title":"Blood"},{"key":"B104","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/jcmm.13935","article-title":"CUDC907 blocks multiple prosurvival signals and abrogates microenvironment protection in CLL","volume":"23","author":"Chen","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0540","article-title":"Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway","author":"Kern","year":"2004","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.54254\/3049-5458\/2025.25358","article-title":"Microenvironmental reprogramming in chronic lymphocytic leukemia proliferation centers: from metabolic-EV Regulation to targeted therapeutic breakthroug","volume":"3","author":"Cheng","year":"2025","journal-title":"J Clin Technol Theory"},{"key":"B107","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41420-024-02153-6","article-title":"Tuning the B-CLL microenvironment: evidence for BAG3 protein- mediated regulation of stromal fibroblasts activity","volume":"10","author":"Basile","year":"2024","journal-title":"Cell Death Discov"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41375-022-01586-1","article-title":"The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia","volume":"36","author":"Rusyn","year":"2022","journal-title":"Leukemia"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-125827","article-title":"Expansion of T helper cell subsets in chronic lymphocytic leukemia cell co-cultures with nurselike cells","volume":"36","author":"Vaca","year":"2019","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiad006","article-title":"Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion","volume":"113","author":"Le Saos-Patrinos","year":"2023","journal-title":"J Leukoc Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10875-022-01255-z","article-title":"Atypical autosomal recessive AID deficiency\u2014Yet another piece of the hyper-igM puzzle","volume":"42","author":"Della Mina","year":"2022","journal-title":"J Clin Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004157","article-title":"Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study","volume":"20","author":"Qin","year":"2023","journal-title":"PloS Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000533234","article-title":"Immune dysfunction and infection \u2013 interaction between CLL and treatment: A reflection on current treatment paradigms and unmet needs","volume":"147","author":"Gargiulo","year":"2023","journal-title":"Acta Haematol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1182\/blood-2023-185741","article-title":"Outcomes and treatment sequences of therapies with BCL2- and BTK inhibitors in chronic lymphocytic leukemia (CLL): an analysis of patient data within the german CLL study group (GCLLSG) registry","volume":"142","author":"Kutsch","year":"2023","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073193","article-title":"Double strike in chronic lymphocytic leukemia\u2014The combination of BTK and BCL2 inhibitors in actual and future clinical practice","volume":"26","author":"Zygmunciak","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40364-022-00357-5","article-title":"Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma","volume":"10","author":"Zhang","year":"2022","journal-title":"biomark Res"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s12672-025-02947-9","article-title":"Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia","volume":"16","author":"Hays","year":"2025","journal-title":"Discover Oncol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1182\/bloodadvances.2021006574","article-title":"BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL","volume":"6","author":"Pleyer","year":"2022","journal-title":"Blood Adv"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1080\/10428194.2022.2064995","article-title":"The role of BTK inhibitors on the tumor microenvironment in CLL","volume":"63","author":"McCay","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"B120","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1182\/blood-2019-125647","article-title":"CAR T cells derived from healthy mice lead to cytokine release syndrome (CRS) in the TCL1 chronic lymphocytic leukemia model; mice with CLL treated with acalabrutinib or ibrutinib have improved CAR T cell function without increasing the cytokines of CRS","volume":"134","author":"Sanderson","year":"2019","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1182\/blood-2018-99-116444","article-title":"Modulation of T-cell function in the microenvironment of emu-TCL1 CLL bearing mice by btki appears independent of ITK","volume":"132","author":"Schwarzbich","year":"2018","journal-title":"Blood"},{"key":"B122","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1182\/blood.V122.21.4182.4182","article-title":"In patients with chronic lymphocytic leukemia (CLL) ibrutinib effectively reduces clonal igM paraproteins and serum free light chains while increasing normal igM, igA serum levels, suggesting a nascent recovery of humoral immunity","volume":"122","author":"Farooqui","year":"2013","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27218","article-title":"Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARSCoV2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL","volume":"99","author":"Campanella","year":"2024","journal-title":"Am J Hematol Oncol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006785","article-title":"BCL2 inhibitors and MCL1 inhibitors for hematological Malignancies","volume":"138","author":"Roberts","year":"2021","journal-title":"Blood"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-023-03702-7","article-title":"Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view","volume":"484","author":"Riedl","year":"2024","journal-title":"Virchows Arch"},{"key":"B126","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.12427","article-title":"The induction of immunogenic cell death by type II antiCD20 monoclonal antibodies has mechanistic differences compared with type I rituximab","volume":"162","author":"Cheadle","year":"2013","journal-title":"Br J Haematol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X21500300","article-title":"CD39\/CD73\/A2a adenosine metabolic pathway: targets for moxibustion in treating DSS-induced ulcerative colitis","volume":"49","author":"Zhu","year":"2021","journal-title":"Am J Chin Med (Gard City N Y)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000610","article-title":"Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade","volume":"8","author":"Yang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6074.TUMIMM22-B08","article-title":"Abstract B08: AB598, a therapeutic anti-CD39 antibody, elevates ATP and increases immunogenicity in the tumor microenvironment","volume":"10","author":"Parashar","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1182\/blood-2024-209744","article-title":"CD39, CD73 and the adenosine pathway mediate immune escape in juvenile myelomonocytic leukemia (JMML)","volume":"144","author":"Rajak","year":"2024","journal-title":"Blood"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-LB166","article-title":"Abstract LB166: Discovery of CT3021, a novel potent adenosine A2a\/A2b\/A1 receptor triple antagonist","volume":"84","author":"Han","year":"2024","journal-title":"Cancer Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12774","article-title":"Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis","volume":"165","author":"Dulphy","year":"2014","journal-title":"Br J Haematol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1182\/blood-2019-126478","article-title":"Mechanisms of Tolerance Induction through T Regulatory Cells during Chemotherapy-Mediated Immunogenic Cell Death in Acute Myeloid Leukemia","volume":"134","author":"Ocadlikova","year":"2019","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-3499","article-title":"Abstract 3499: M1069 as dual A2A\/A2B adenosine receptor antagonist counteracts immune-suppressive mechanisms of adenosine and reduces tumor growth in vivo","volume":"82","author":"Zaynagetdinov","year":"2022","journal-title":"Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-2890","article-title":"Abstract 2890: Investigating dynamic IDO-Kyn-Ahr pathway induced tumor immunosuppression using imaging modality to optimize therapeutic Intervention","volume":"83","author":"Bah","year":"2023","journal-title":"Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioaf102","article-title":"IDO can improve ovarian function in premature ovarian insufficiency via AhR and regulatory T cells","volume":"113","author":"Hu","year":"2025","journal-title":"Biol Reprod"},{"key":"B137","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2018-99-112497","article-title":"Up-regulation of immune tolerance genes in leukemic mesenchymal stromal cells is induced by acute myeloid leukemia cells through an IFN-gamma-dependent inflammatory signaling","volume":"132","author":"Ciciarello","year":"2018","journal-title":"Blood"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1182\/blood-2019-126512","article-title":"Interferon-\u03b3-dependent inflammatory signature in acute myeloid leukemia cells is able to shape stromal and immune bone marrow microenvironment","volume":"134","author":"Ciciarello","year":"2019","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41467-018-03066-6","article-title":"Structural basis for amino acid transport by the CAT family of SLC7 transporters","volume":"9","author":"Jungnickel","year":"2018","journal-title":"Nat Commun"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101848","article-title":"Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients","volume":"9","author":"Giallongo","year":"2014","journal-title":"PloS One"},{"key":"B142","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41392-021-00598-0","article-title":"Lactate-avid regulatory T cells: metabolic plasticity controls immunosuppression in tumour microenvironment","volume":"6","author":"Multhoff","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00417","article-title":"The warburg effect is associated with tumor aggressiveness in testicular germ cell tumors","volume":"10","author":"Bonatelli","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"73364","DOI":"10.18632\/oncotarget.20639","article-title":"PD-L1\/PD-1: new kid on the ``immune metabolic\u2019\u2019 block","volume":"8","author":"Qorraj","year":"2017","journal-title":"Oncotarget"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-15-PL07-01","article-title":"Abstract PL07-01: Altered metabolism in leukemic microenvironment","volume":"14","author":"Konopleva","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019056","article-title":"Palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML","volume":"142","author":"Shao","year":"2023","journal-title":"Blood"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1158\/0008-5472.CAN-23-1006","article-title":"Oxidative phosphorylation fueled by fatty acid oxidation sensitizes leukemic stem cells to cold","volume":"83","author":"Griessinger","year":"2023","journal-title":"Cancer Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood-2021-150699","article-title":"Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia","volume":"138","author":"Weinh\u00e4user","year":"2021","journal-title":"In Vivo. Blood"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2023.00160","article-title":"Lactate metabolic pathway regulates tumor cell metastasis and its use as a new therapeutic target","volume":"4","author":"Xing","year":"2023","journal-title":"Explor Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41419-024-07122-6","article-title":"Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment","volume":"15","author":"Zheng","year":"2024","journal-title":"Cell Death Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400538","article-title":"Enhanced osteosarcoma immunotherapy via caCO3 nanoparticles: remodeling tumor acidic and immune microenvironment for photodynamic therapy","volume":"13","author":"Gao","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B152","doi-asserted-by":"publisher","first-page":"eadv0885","DOI":"10.1200\/JCO.2024.42.16_suppl.e16204","article-title":"Magnesium microspheres to enhance lipiodol-mediated transarterial chemo-embolization (TACE) of hepatocellular carcinoma: From bench to a pilot clinical study","volume":"11","author":"Zheng","year":"2024","journal-title":"J Clin Oncol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030569","article-title":"In vitro and in vivo characterization of MCT1 inhibitor AZD3965 confirms preclinical safety compatible with breast cancer treatment","volume":"13","author":"Benyahia","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2260","article-title":"Genetic disruption of lactate\/H+ symporters (MCTs) and their subunit CD147\/BASIGIN sensitizes glycolytic tumor cells to phenformin","author":"Marchiq","year":"2015","journal-title":"Cancer Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1356415","article-title":"A role for tunneling nanotubes in virus spread","volume":"15","author":"Lv","year":"2024","journal-title":"Front Microbiol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302551","article-title":"Tunneling nanotubes and tumor microtubes\u2014Emerging data on their roles in intercellular communication and pathophysiology: Summary of an International FASEB Catalyst Conference October 2023","volume":"38","author":"Lou","year":"2024","journal-title":"FASEB J"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1242\/jcs.083279","article-title":"Wiring through tunneling nanotubes \u2013 from electrical signals to organelle transfer","volume":"125","author":"Abounit","year":"2012","journal-title":"J Cell Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.619697","article-title":"Intercellular communication by vascular endothelial cell-derived extracellular vesicles and their microRNAs in respiratory diseases","volume":"7","author":"Fujimoto","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646595","article-title":"Extracellular vesicles mediate intercellular communication: Transfer of functionally active microRNAs by microvesicles into phagocytes","volume":"47","author":"Classen","year":"2017","journal-title":"Eur J Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102533","article-title":"Extracellular vesicles (Exosomes) as immunosuppressive mediating variables in tumor and chronic inflammatory microenvironments","volume":"10","author":"Awadasseid","year":"2021","journal-title":"Cells"},{"key":"B161","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1182\/blood-2018-99-112933","article-title":"Mitochondrial transfer confers microenvironment-mediated resistance to oxphos inhibition in AML","volume":"132","author":"Yang","year":"2018","journal-title":"Blood"},{"key":"B162","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1158\/1538-7445.AM2023-3860","article-title":"Abstract 3860: ERK1\/2 inhibition overcomes resistance to venetoclax in AML by altering mitochondrial metabolism","volume":"84","author":"Sharma","year":"2023","journal-title":"Cancer Res"},{"key":"B163","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1182\/blood-2023-181245","article-title":"Activation of GCN2 by HC-7366 results in significant anti-tumor efficacy as monotherapy and overcomes resistance mechanisms when combined with venetoclax in AML","volume":"142","author":"Tameire","year":"2023","journal-title":"Blood"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061446","article-title":"Synergy of venetoclax and 8-chloro-adenosine in AML: the interplay of rRNA inhibition and fatty acid metabolism","volume":"14","author":"Hoang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B165","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1182\/blood-2024-210698","article-title":"ERK1\/2 inhibition mediates bax dependent proteolysis of OPA1 and induces mitochondrial cristae remodeling to overcome resistance to venetoclax","volume":"144","author":"Sharma","year":"2024","journal-title":"Blood"},{"key":"B166","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12964-025-02287-9","article-title":"Mechanisms of electroacupuncture-induced neuroprotection in acute stroke rats: the role of astrocyte-mediated mitochondrial transfer","volume":"23","author":"Guo","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-4069","article-title":"Abstract 4069: IL12-expressing genetically engineered myeloid cells remodel the stromal dense and T cell poor tumor microenvironment and premetastatic niche of F42010 murine osteosarcoma","volume":"84","author":"Jackett","year":"2024","journal-title":"Cancer Res"},{"key":"B168","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2024-205911","article-title":"Single-cell dissection of the B-ALL niche reveals distinct mesenchymal stromal cell subtypes with differential leukemic cell support and relapse implications","volume":"144","author":"Blanco","year":"2024","journal-title":"Blood"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.37349\/etat.2024.00262","article-title":"Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche","volume":"5","author":"Khattab","year":"2024","journal-title":"Explor Target Antitumor Ther"},{"key":"B170","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1182\/blood-2024-206739","article-title":"Dissecting the interactions between leukemic cells and the aging bone marrow niche","volume":"144","author":"Perez","year":"2024","journal-title":"Blood"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-5155","article-title":"Abstract 5155: Targeting tumor infiltrating myeloid cells in prostate cancer","volume":"83","author":"De Velasco","year":"2023","journal-title":"Cancer Res"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2023.03.07","article-title":"Immune evasion and therapeutic opportunities based on natural killer cells","volume":"35","author":"Zhang","year":"2023","journal-title":"Chin J Cancer Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03114-0","article-title":"Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis","author":"Tang","year":"2024","journal-title":"Oncogene"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003715","article-title":"T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion","volume":"10","author":"Morton","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B175","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12964-022-00900-9","article-title":"Ceramide synthesis regulates biogenesis and packaging of exosomal MALAT1 from adipose derived stem cells, increases dermal fibroblast migration and mitochondrial function","volume":"21","author":"Kong","year":"2023","journal-title":"Cell Communication Signaling"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407695","article-title":"Shrimp virus regulates ROS dynamics via the nrf2 pathway to facilitate viral replication","volume":"12","author":"He","year":"2025","journal-title":"Adv Sci"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00267","article-title":"Trilobatin protects against oxidative injury in neuronal PC12 cells through regulating mitochondrial ROS homeostasis mediated by AMPK\/nrf2\/sirt3 signaling pathway","volume":"11","author":"Gao","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1547940","article-title":"RvD2 mitigates TNF-Induced mitochondrial reactive oxygen species through NRF2 signaling in placental trophoblasts","volume":"16","author":"Hahka","year":"2025","journal-title":"Front Physiol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01171","article-title":"Regulation of tolerogenic features on dexamethasone-modulated MPLA-activated dendritic cells by MYC","volume":"10","author":"Garc\u00eda-Gonz\u00e1lez","year":"2019","journal-title":"Front Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq0021","article-title":"Combination bezafibrate and nivolumab treatment of patients with advanced non\u2013small cell lung cancer","volume":"14","author":"Tanaka","year":"2022","journal-title":"Sci Transl Med"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092400","article-title":"Cotargeting of mitochondrial complex I and bcl-2 shows antileukemic activity against acute myeloid leukemia cells reliant on oxidative phosphorylation","volume":"12","author":"Liu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B182","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1182\/blood-2019-124475","article-title":"Mitochondrial oxphos as survival mechanism of minimal residual AML cells after induction chemotherapy: survival benefit by complex I inhibition with iacs-010759","volume":"134","author":"Han","year":"2019","journal-title":"Blood"},{"key":"B183","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1182\/blood.V124.21.622.622","article-title":"Novel nanomolar potency mitochondrial complex I inhibitor iacs-1131 selectively kills oxphos-dependent AML cells","volume":"124","author":"Matre","year":"2014","journal-title":"Blood"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512222","article-title":"Dysregulated signalling pathways driving anticancer drug resistance","volume":"24","author":"Antoun","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B185","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20517\/cdr.2025.90","article-title":"Lactylation: a novel driver of drug resistance in the tumor microenvironment","volume":"8","author":"Li","year":"2025","journal-title":"Cancer Drug Resistance"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1581964","article-title":"Tumor-derived vesicles in immune modulation: focus on signaling pathways","volume":"16","author":"Yin","year":"2025","journal-title":"Front Immunol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3390\/cells14070530","article-title":"B7H3 in gastrointestinal tumors: role in immune modulation and cancer progression: A review of the literature","volume":"14","author":"Mielcarska","year":"2025","journal-title":"Cells"},{"key":"B188","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-025-02345-3","article-title":"A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities","volume":"24","author":"Alizadeh","year":"2025","journal-title":"Mol Cancer"},{"key":"B189","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/biof.1799","article-title":"Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer","volume":"48","author":"Kooshki","year":"2021","journal-title":"Biofactors"},{"key":"B190","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10555-021-09995-x","article-title":"Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer","volume":"40","author":"Sempere","year":"2021","journal-title":"Cancer Metastasis Review"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1619597","article-title":"Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities","volume":"13","author":"Yin","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00154","article-title":"Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell","volume":"6","author":"Karakasiliotis","year":"2015","journal-title":"Front Physiol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1182\/blood-2019-130540","article-title":"Identification of gene expression signatures in leukemia stem cells and minimal residual disease following treatment of adverse risk acute myeloid leukemia","volume":"134","author":"Issa","year":"2019","journal-title":"Blood"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.853620","article-title":"Editorial: new insights into the complexity of tumor immunology in B-cell Malignancies: tumor immunology and immunotherapy","volume":"12","author":"Seiffert","year":"2022","journal-title":"Front Oncol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3390\/cells14080562","article-title":"Glioblastoma stem cells at the nexus of tumor heterogeneity, immune evasion, and therapeutic resistance","volume":"14","author":"Tang","year":"2025","journal-title":"Cells"},{"key":"B196","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13287-025-04438-8","article-title":"Pharmacological modulation of stem cells signaling pathway for therapeutic applications","volume":"16","author":"Alnasser","year":"2025","journal-title":"Stem Cell Res Ther (Walnut)"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3390\/genes15121597","article-title":"Wnt signaling pathway in tumor biology","volume":"15","author":"Iluta","year":"2024","journal-title":"Genes (Basel)"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","article-title":"Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)","volume":"51","author":"Katoh","year":"2017","journal-title":"Int J Oncol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3390\/genes15121597","article-title":"Significance of wnt signaling pathway in the pathogenesis of acute myeloid leukemia","volume":"15","author":"Patel","year":"2019","journal-title":"IJSRM"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1614707","article-title":"Deciphering the secrets of tumor-initiating cells in pancreatic ductal adenocarcinoma microenvironment: mechanisms and therapeutic opportunities","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Immunol"},{"key":"B201","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1182\/blood.V124.21.1970.1970","article-title":"CLL sera drive maturation of normal monocytes to M2-like macrophages by direct and indirect mechanisms","volume":"124","author":"Marsilio","year":"2014","journal-title":"Blood"},{"key":"B202","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1182\/blood-2023-189715","article-title":"Inflammation shapes the transcriptional landscape of the bone marrow microenvironment in post-transplantation leukemia relapses","volume":"142","author":"Rovatti","year":"2023","journal-title":"Blood"},{"key":"B203","doi-asserted-by":"publisher","first-page":"P5-P5-06-10","DOI":"10.1158\/1538-7445.SABCS21-P5-06-10","article-title":"Abstract P5-06-10: Tumor microenvironment modulates ganglioside expression leading to immunosuppression in triple negative breast cancer","volume":"82","author":"Anand","year":"2022","journal-title":"Cancer Res"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.14.585083","article-title":"Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging","volume":"187","author":"Bandyopadhyay","year":"2024","journal-title":"bioRxiv"},{"key":"B205","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1182\/blood-2018-99-113495","article-title":"Niche heterogeneity impacts evolution of myeloproliferative neoplasms driven by the same oncogenic pathway","volume":"132","author":"Korn","year":"2018","journal-title":"Blood"},{"key":"B206","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11899-023-00688-6","article-title":"The bone marrow immune microenvironment in CML: treatment responses, treatment-free remission, and therapeutic vulnerabilities","volume":"18","author":"Patterson","year":"2023","journal-title":"Curr Hematol Malig Rep"},{"key":"B207","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1182\/blood-2024-211878","article-title":"Lama4 deficiency leads to delayed onset of chronic myeloid leukemia possibly by providing an unfavorable niche","volume":"144","author":"Mansson","year":"2024","journal-title":"Blood"},{"key":"B208","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/HEP.0000000000000591","article-title":"Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma","volume":"79","author":"Li","year":"2023","journal-title":"Hepatology"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2026019","article-title":"Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma","volume":"11","author":"Kim","year":"2022","journal-title":"Oncoimmunology"},{"key":"B210","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1182\/blood-2023-178589","article-title":"CD74 + Leukemia-associated macrophages supporess T cell immune surveillance and promote leukemic cell growth in acute myeloid leukemia","volume":"142","author":"Qiu","year":"2023","journal-title":"Blood"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-151400","article-title":"Lysosomal acid lipase a (LIPA) modulates leukemia stem cell (LSC) response to venetoclax\/TKI combination therapy in blast phase chronic myeloid leukemia","volume":"110","author":"Minhajuddin","year":"2021","journal-title":"Blood"},{"key":"B212","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1182\/blood.V112.11.546.546","article-title":"Molecular basis of proliferation\/survival and migration of CLL in peripheral blood, bone marrow and lymph nodes","volume":"112","author":"Mittal","year":"2008","journal-title":"Blood"},{"key":"B213","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1182\/blood-2024-209875","article-title":"Analysis of the secretome of primary CLL cells in different in vitro co-culture systems","volume":"144","author":"Osswald","year":"2024","journal-title":"Blood"},{"key":"B214","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1182\/blood.V118.21.2538.2538","article-title":"Chronic lymphocytic leukemia: proliferative and apoptotic profile on lymph node, studied by immunohistochemistry including the proliferation centers","volume":"118","author":"Sachanas","year":"2011","journal-title":"Blood"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.exphem.2023.06.156","article-title":"Vascular cell adhesion molecule-1 regulates bone marrow mesenchymal stem cell maintenance and niche function","volume":"142","author":"Di Staulo","year":"2023","journal-title":"Blood"},{"key":"B216","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00262-024-03791-6","article-title":"Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma","volume":"73","author":"Li","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B217","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1111\/cas.15932","article-title":"Singlecell RNAseq reveals a microenvironment and an exhaustion state of T\/NK cells in acute myeloid leukemia","volume":"114","author":"Zhang","year":"2023","journal-title":"Cancer Sci"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.24.644582","article-title":"Integrated single-cell and spatial analysis identifies context-dependent myeloid-T cell interactions in head and neck cancer immune checkpoint blockade response","author":"Golfinos-Owens","year":"2025","journal-title":"bioRxiv"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1129343","article-title":"Modulation of T-cell function by myeloid-derived suppressor cells in hematological Malignancies","volume":"11","author":"Bhardwaj","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2022.133","article-title":"Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment","volume":"6","author":"Tabe","year":"2023","journal-title":"Cancer Drug Resistance"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143398","article-title":"``FLipping\u2019\u2019 the story: FLT3-mutated acute myeloid leukemia and the evolving role of FLT3 inhibitors","volume":"14","author":"Knight","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B222","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/13543784.2024.2388567","article-title":"Investigational CXCR4 inhibitors in early phase development for the treatment of hematological Malignancies","volume":"33","author":"Martino","year":"2024","journal-title":"Expert Opin Investig Drugs"},{"key":"B223","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000534443","article-title":"Genetic\/epigenetic alteration and tumor immune microenvironment in intrahepatic cholangiocarcinoma: transforming the immune microenvironment with molecular-targeted agents","volume":"13","author":"Nishida","year":"2023","journal-title":"Liver Cancer"},{"key":"B224","doi-asserted-by":"publisher","first-page":"18","DOI":"10.20517\/cdr.2023.100","article-title":"Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them","volume":"7","author":"Borogovac","year":"2024","journal-title":"Cancer Drug Resistance"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1544532","article-title":"Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.15761\/CRR.1000203","article-title":"Targeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapy","volume":"4","author":"Tang","year":"2020","journal-title":"Cancer Rep Rev"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3324\/haematol.2023.283818","article-title":"Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemia","volume":"109","author":"Lyons","year":"2024","journal-title":"Haematologica"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1343378","article-title":"Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy","volume":"15","author":"Mehrabadi","year":"2024","journal-title":"Front Immunol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"S865","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS6104","article-title":"Phase 2 trial of retifanlimab (anti\u2013PD-1) in combination with INCAGN02385 (anti\u2013LAG-3) and INCAGN02390 (anti\u2013TIM-3) as first-line treatment in patients with PD-L1\u2013positive recurrent\/metastatic squamous cell carcinoma of the head and neck","volume":"33","author":"Cohen","year":"2023","journal-title":"J Clin Oncol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1323914","article-title":"Immune checkpoint blockade in hematological Malignancies: current state and future potential","volume":"14","author":"Pophali","year":"2024","journal-title":"Front Oncol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-019-0746-1","article-title":"Immune checkpoint blockade and CAR-T cell therapy in hematologic Malignancies","volume":"12","author":"Wang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"48","DOI":"10.54254\/2753-8818\/2025.LD25961","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms of action, therapeutic efficacy, and emerging combination strategies","volume":"8","author":"Gao","year":"2025","journal-title":"Theor Natural Science"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231186027","article-title":"The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition","volume":"15","author":"Kreidieh","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/blood.V126.23.389.389","article-title":"A phase II study evaluating the safety and efficacy of subcutaneous plerixafor for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in recipients with hematological Malignancies","volume":"126","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"B235","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1182\/blood.V126.23.4412.4412","article-title":"Hematopoietic stem cell mobilization for gene therapy: the combination of G-CSF+Plerixafor in patients with beta-thalassemia major provides high yields of CD34+ Cells with primitive signatures","volume":"126","author":"Baiamonte","year":"2015","journal-title":"Blood"},{"key":"B236","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2021-145759","article-title":"Mavorixafor, an oral CXCR4 antagonist, for treatment of patients with WHIM syndrome: results from the long-term extension of the open-label phase 2 study","volume":"138","author":"Dale","year":"2021","journal-title":"Blood"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1182\/blood-2018-99-119840","article-title":"Determination of phase 3 dose for X4P-001 in patients with WHIM syndrome","volume":"132","author":"Dale","year":"2018","journal-title":"Blood"},{"key":"B238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/ehm.11.78","article-title":"Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust","volume":"5","author":"Stroncek","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"B239","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1182\/blood-2019-123816","article-title":"A double-blind, placebo-controlled, phase 3 registration trial to evaluate the efficacy of uproleselan (GMI-1271) with standard salvage chemotherapy in patients with relapsed\/refractory (R\/R) acute myeloid leukemia","volume":"134","author":"DeAngelo","year":"2019","journal-title":"Blood"},{"key":"B240","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1182\/blood-2019-126271","article-title":"The first-in-class anti-CD47 antibody magrolimab (5F9) in combination with azacitidine is effective in MDS and AML patients: ongoing phase 1b results","volume":"134","author":"Sallman","year":"2019","journal-title":"Blood"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.7009","article-title":"The first-in-class anti-CD47 antibody Hu5F9-G4 is active and well tolerated alone or with azacitidine in AML and MDS patients: Initial phase 1b results","volume":"37","author":"Sallman","year":"2019","journal-title":"J Clin Oncol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-021-03815-z","article-title":"Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective","volume":"148","author":"Chen","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 blockade by hu5F9G4 and rituximab in nonHodgkin\u2019s lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"New Engl J Med"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-4150","article-title":"Abstract 4150: Enriching for adenosine antagonist patient responses through deep learning","volume":"82","author":"Alt","year":"2022","journal-title":"Cancer Res"},{"key":"B245","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1182\/blood-2024-209220","article-title":"Full-spectrum flow cytometry analysis reveals dynamics of T cell function of pediatric B-cell precursor acute lymphoblastic leukemia during continuous infusion of blinatumomab","volume":"144","author":"Zhang","year":"2024","journal-title":"Blood"},{"key":"B246","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.V128.22.2059.2059","article-title":"Immune checkpoint blockade combinations as promising strategy for cancer immunotherapy in multiple myeloma patients","volume":"128","author":"Castella","year":"2016","journal-title":"Blood"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12020336","article-title":"Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients","volume":"12","author":"Davidsson","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.78","article-title":"Leukemia cell mobilization: a road to eradication","volume":"50","author":"Copelan","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.5c00126","article-title":"Synthesis, characterization, interactions, and immunomodulatory function of ectonucleotidase CD39\/CD73 inhibitor 8-butylthioadenosine 75\u2019-monophosphate","author":"Bi","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1177\/1010428319837138","article-title":"The metabolic milieu in melanoma: Role of immune suppression by CD73\/adenosine","volume":"41","author":"Passarelli","year":"2019","journal-title":"Tumour Biol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"e16171","DOI":"10.1200\/JCO.2025.43.16_suppl.e16171","article-title":"Multi-omics investigation for the tumor immune microenvironment and spatial heterogeneity in hepatocellular carcinoma with PVTT: MyCAFs and NID1 in immune evasion","volume":"43","author":"Han","year":"2025","journal-title":"J Clin Oncol"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e17603","article-title":"Multi-omics analysis reveals spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer","volume":"40","author":"Chen","year":"2022","journal-title":"J Clin Oncol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1182\/blood-2024-204226","article-title":"Deconvolving immunologic networks of the AML marrow microenvironment with spatial multi-omic profiling","volume":"144","author":"Maurer","year":"2024","journal-title":"Blood"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.08.495292","article-title":"Single-cell multi-omics defines the cell-type specific impact of splicing aberrations in human hematopoietic clonal outgrowths","volume":"30","author":"Gaiti","year":"2022","journal-title":"bioRxiv"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2024.100435","article-title":"Distinct pathogenesis of clonal hematopoiesis revealed by single-cell multi-omics sequencing","volume":"21","author":"Nakagawa","year":"2024","journal-title":"Blood"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2020-6038","article-title":"Abstract 6038: Combined targeting of E-selectin\/CXCR4 and FLT3 by GMI-1359 and sorafenib effectively reduces leukemia cell burden and protects normal hematopoiesis in a patient-derived AML xenograft model","volume":"80","author":"Zhang","year":"2020","journal-title":"Tumor Biol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1182\/blood.V128.22.2826.2826","article-title":"Administration of the dual E-selectin\/CXCR4 antagonist, GMI-1359, results in a unique profile of tumor mobilization from the bone marrow and facilitation of chemotherapy in a murine model of FLT3 ITD AML","volume":"128","author":"Fogler","year":"2016","journal-title":"Blood"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140984","article-title":"Combined blockage of E-selectin and CXCR4 (GMI-1359) enhances anti-leukemia effect of FLT3 inhibition (Sorafenib) and protects hematopoiesis in pre-clinical AML models","volume":"136","author":"Zhang","year":"2020","journal-title":"Blood"},{"key":"B259","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2024-203706","article-title":"Phase 1b\/2 study of magrolimab (Magro), azacitidine (AZA) and venetoclax (VEN) in patients (pts) with newly diagnosed (ND) older\/unfit or high risk acute myeloid leukemia (AML) and relapsed refractory (R\/R) AML: final clinical data and genomic markers of resistance\/relapse","volume":"144","author":"Arora","year":"2024","journal-title":"Blood"},{"key":"B260","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1182\/bloodadvances.2023012120","article-title":"Prophylactic maintenance with venetoclax\/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML","volume":"8","author":"Garcia","year":"2024","journal-title":"Blood Adv"},{"key":"B261","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1182\/blood-2021-153638","article-title":"Phase I\/II study of azacitidine (AZA) with venetoclax (VEN) and magrolimab (Magro) in patients (pts) with newly diagnosed older\/unfit or high-risk acute myeloid leukemia (AML) and relapsed\/refractory (R\/R) AML","volume":"138","author":"Daver","year":"2021","journal-title":"Blood"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-CT525","article-title":"Abstract CT525: GDX012U-001 A phase 1, open-label, dose escalation, and dose expansion study to assess the safety, tolerability, and preliminary antileukemic activity of GDX012 in patients with MRD positive AML","volume":"82","author":"Knowles","year":"2022","journal-title":"Cancer Res"},{"key":"B263","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2021-154181","article-title":"Multiparametric flow cytometry evaluation of CD200L\/CD200R- LSC\/NK synapse including leukemia stem cell (LSC) fraction as a potential therapeutic target and marker of NK cell exhaustion in pediatric AML-conect-AML french collaborative network","volume":"138","author":"Plesa","year":"2021","journal-title":"Blood"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.358","article-title":"The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment","volume":"31","author":"Fan","year":"2017","journal-title":"Leukemia"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.673506","article-title":"The complexity of the tumor microenvironment and its role in acute lymphoblastic leukemia: implications for therapies","volume":"11","author":"Simioni","year":"2021","journal-title":"Front Oncol"},{"key":"B266","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1182\/blood.V120.21.4736.4736","article-title":"Bone marrow mesenchymal stromal cells protect acute lymphocytic leukemia cells from cytotoxic agents via MAPK\/erk and wnt\/\u03b2-catenin signal pathways","volume":"120","author":"Hu","year":"2012","journal-title":"Blood"},{"key":"B267","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1182\/blood-2024-204988","article-title":"Characterizing the bone marrow stromal niche in pediatric acute myeloid leukemia","volume":"144","author":"Schweighart","year":"2024","journal-title":"Blood"},{"key":"B268","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1182\/blood-2023-180815","article-title":"Bioelectric reprogramming of the bone marrow niche in acute myeloid leukemia","volume":"142","author":"Borella","year":"2023","journal-title":"Blood"},{"key":"B269","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.V118.21.732.732","article-title":"A novel view of paroxysmal nocturnal hemoglobinuria (PNH) pathogenesis: do pathologic PNH hematopoietic stem\/progenitor cells (HSPCs) displace normal HSPCs from their niches in bone marrow because they are more motile due to defective adhesion and enhanced migratory properties","volume":"118","author":"Ratajczak","year":"2011","journal-title":"Blood"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6074.IO2025-B056","article-title":"Abstract B056: Thrombospondin-1:CD47 signaling contributes to the development of T cell exhaustion in cancer","volume":"26","author":"Weng","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70345","article-title":"Unravelling T cell exhaustion through coinhibitory receptors and its transformative role in cancer immunotherapy","volume":"15","author":"Xiang","year":"2025","journal-title":"Clin Transl Med"},{"key":"B272","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-025-03477-6","article-title":"Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1\u03b1 axis in hepatocellular carcinoma","volume":"44","author":"Liu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-91287-5_27","article-title":"Hypoxia-\/HIF-1\u03b1-driven factors of the tumor microenvironment impeding antitumor immune responses and promoting Malignant progression","volume":"1072","author":"Vaupel","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaf365","article-title":"Sonodynamic therapy augmented by glycolysis inhibition: a novel metabolic reprogramming strategy for enhanced osteosarcoma treatment","volume":"12","author":"Song","year":"2025","journal-title":"Natl Sci Rev"},{"key":"B275","doi-asserted-by":"publisher","first-page":"1752384","DOI":"10.61958\/NCJT1177","article-title":"Clear cell renal cell carcinoma and metabolic reprogramming: New therapeutic targets for kidney cancer treatment","volume":"16","author":"Dou","year":"2025","journal-title":"New Cell"},{"key":"B276","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2008.26","article-title":"Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia","volume":"22","author":"Steelman","year":"2008","journal-title":"Leukemia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1743920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:54:21Z","timestamp":1771926861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1743920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":276,"alternative-id":["10.3389\/fimmu.2026.1743920"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1743920","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"article-number":"1743920"}}